Seth Seegobin
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 9
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 1
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- J. Wanders (9 shared papers)Javier Cortés (9 shared papers)Linda T. Vahdat (8 shared papers)Joyce O’Shaughnessy (2 shared papers)Fátima Cardoso (3 shared papers)Corina E. Dutcus (2 shared papers)Katarína Petráková (3 shared papers)P. Chollet (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer Research (3 papers)PLoS Genetics (2 papers)Open Forum Infectious Diseases (2 papers)Bioinformatics (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Seth Seegobin
19 papers receiving 1.3k citations
Seth Seegobin's Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 798
- Cancer Research 257
- Dermatology 151
- Pulmonary and Respiratory Medicine 293
- Rheumatology 110
Countries citing papers authored by Seth Seegobin
This map shows the geographic impact of Seth Seegobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth Seegobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth Seegobin more than expected).
Fields of papers citing papers by Seth Seegobin
This network shows the impact of papers produced by Seth Seegobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth Seegobin. The network helps show where Seth Seegobin may publish in the future.
Co-authors
The 25 scholars most cited alongside Seth Seegobin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study Hit paper breakdown → | 2011 | 807 |
| 2 | 2021 | 112 | |
| 3 | 2017 | 98 | |
| 4 | 2014 | 71 | |
| 5 | 2013 | 55 | |
| 6 | 2014 | 35 | |
| 7 | 2010 | 29 | |
| 8 | 2021 | 24 | |
| 9 | 2015 | 20 | |
| 10 | 2016 | 19 | |
| 11 | 2007 | 11 | |
| 12 | 2010 | 5 | |
| 13 | 2011 | 5 | |
| 14 | 2013 | 4 | |
| 15 | 2010 | 3 | |
| 16 | 2010 | 2 | |
| 17 | 2011 | 2 | |
| 18 | 2019 | 2 | |
| 19 | 2014 | 1 | |
| 20 | 2025 | 0 |
About Seth Seegobin
Seth Seegobin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Rheumatology, Cancer Research and Infectious Diseases, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), HER2/EGFR in Cancer Research (3 papers), Advanced Breast Cancer Therapies (3 papers), Systemic Lupus Erythematosus Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (798 citations), Cancer Research (257 citations), Dermatology (151 citations), Pulmonary and Respiratory Medicine (293 citations) and Rheumatology (110 citations). Seth Seegobin has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include J. Wanders, Javier Cortés, Linda T. Vahdat, Joyce O’Shaughnessy, Fátima Cardoso, Corina E. Dutcus, Katarína Petráková, P. Chollet, Joanne L. Blum and Chris Twelves. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, PLoS Genetics, Open Forum Infectious Diseases and Bioinformatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.